Improving Survival in Younger Patients With Waldenström Macroglobulinemia
Researchers evaluated data from younger patients with Waldenström macroglobulinemia to determine features that predict outcomes in this patient population.
Non-Hodgkin Lymphoma
Development of a Tool to Predict Neurotoxicity Associated With CAR-T Therapy
The occurrence, severity, and need for treatment of cytokine release syndrome were key parameters in the assessment of CAR-T–related neurotoxicity risk.
Strategies for Managing AEs, Patient Adherence in Acalabrutinib for Mantle Cell Lymphoma
Researchers at UT MD Anderson Cancer Center in Houston present tools that support patient adherence to acalabrutinb in the setting of MCL.
Immunohistochemistry as a Surrogate for TP53 Sequencing in Mantle Cell Lymphoma
Identifying TP53 missense mutations through routine analysis is needed for patients with mantle cell lymphoma.
Risk-Stratified Treatments May Offer Cures in Relapsed Pediatric Anaplastic Large Cell Lymphoma
Study results suggest allogeneic SCT as standard consolidation therapy in pediatric patients with progression during frontline therapy or relapse of a CD3-positive ALCL.
No Benefit From Early Rituximab Intensification During DLBCL Treatment
Researchers in the Netherlands conducted HOVON-84 to determine what benefit, if any, early rituximab intensification had in adult patients with untreated DLBCL.
Long-Term Zanubrutinib Treatment Effective for Majority of Patients With Waldenström Macroglobulinemia
The overall response rate was 95.9%, with 100% of patients in the TN group and 93.9% of patients in the RR group responding.
PET-Based Treatment Approach for Diffuse Large B-Cell Lymphoma
A prospective NCTN PET-directed analysis aimed to eradicate the short- and long-term toxicities associated with RT in patients with limited-stage DLBCL.
Systematic Analysis Reveals Genomic Mutational Frequencies in MCL
The authors noted that these findings should be seen as a reference for the mutational landscape in MCL at baseline and at disease progression after treatment.
Examining Progress and Future Directions in Follicular Lymphoma Treatment
Researchers examine how far follicular lymphoma treatment has come, what limitations still remain, and where the management of the disease is headed.
- Loading...
Loading...
Next post in Lymphoma
Loading... 
Loading...